logo

ZLAB

Zai Lab·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ZLAB fundamentals

Zai Lab (ZLAB) released its earnings on Nov 6, 2025: revenue was 116.10M (YoY +13.49%), missed estimates; EPS was -0.33 (YoY -725.00%), missed estimates.
Revenue / YoY
116.10M
+13.49%
EPS / YoY
-0.33
-725.00%
Report date
Nov 6, 2025
ZLAB Earnings Call Summary for Q3,2025
  • Revenue Growth: Q3 2025 revenue up 14% YoY to $116M, driven by VYVGART and NUZYRA.
  • Pipeline Milestones: ZL-1310 Phase III for small cell lung cancer, ZL-1503 IND filing, and KarXT schizophrenia launch in 2027.
  • Profitability: China business profitable with adjusted loss down 28% YoY to $28M.
  • Global Expansion: 2028 $2B revenue target supported by 1310 global approvals and pipeline investments.
  • Cost Efficiency: R&D/SR&D expenses optimized, SG&A up 4% for commercial scale.
EPS
Revenue

Revenue & Expenses

ZLAB has released its 2025 Q3 earnings report, with revenue of 116.09M, reflecting a YoY change of 13.52%, and net profit of -35.96M, showing a YoY change of 13.70%. The Sankey diagram below clearly presents ZLAB's revenue sources and cost distribution.

Key Indicators

Zai Lab (ZLAB) key financial stats and ratios, covering profitability, financial health, and leverage.
Zai Lab (ZLAB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Zai Lab (ZLAB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Zai Lab (ZLAB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Zai Lab (ZLAB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Zai Lab (ZLAB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield